Erech Finance Cahalacha Ltd (TA:EFNC) — Market Cap & Net Worth
Market Cap & Net Worth: Erech Finance Cahalacha Ltd (EFNC)
Erech Finance Cahalacha Ltd (TA:EFNC) has a market capitalization of $1.14 Million (ILA423.67 Million) as of September 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30620 globally and #450 in its home market, demonstrating a 19.29% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Erech Finance Cahalacha Ltd's stock price ILA167.00 by its total outstanding shares 2536960 (2.54 Million). Also see EFNC current and non-current assets for a full breakdown of the balance sheet.
Erech Finance Cahalacha Ltd Market Cap History: 2015 to 2026
Erech Finance Cahalacha Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.99 Billion to $1.14 Million (-53.61% CAGR). Also see how efficiently does Erech Finance Cahalacha Ltd generate cash for how efficiently the company converts equity into cash flow.
Erech Finance Cahalacha Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Erech Finance Cahalacha Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Erech Finance Cahalacha Ltd share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
11.46x
Erech Finance Cahalacha Ltd's market cap is 11.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.99 Billion | $195.00K | -$15.77 Million | 10204.97x | N/A |
| 2016 | $129.75 Million | $83.00K | -$8.95 Million | 1563.21x | N/A |
| 2017 | $23.53 Million | $40.00K | -$7.01 Million | 588.16x | N/A |
| 2018 | $13.17 Million | $9.81 Million | -$10.30 Million | 1.34x | N/A |
| 2019 | $23.13 Million | $6.59 Million | -$6.78 Million | 3.51x | N/A |
| 2020 | $42.43 Million | $10.07 Million | $1.34 Million | 4.21x | 31.55x |
| 2021 | $23.09 Million | $13.39 Million | $1.02 Million | 1.72x | 22.55x |
| 2022 | $4.28 Million | $10.65 Million | -$25.04 Million | 0.40x | N/A |
| 2023 | $3.23 Million | $282.00K | -$25.29 Million | 11.46x | N/A |
Competitor Companies of EFNC by Market Capitalization
Companies near Erech Finance Cahalacha Ltd in the global market cap rankings as of September 17, 2026. Review EFNC tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Erech Finance Cahalacha Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Erech Finance Cahalacha Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Erech Finance Cahalacha Ltd's market cap moved from $1.99 Billion to $ 1.14 Million, with a yearly change of -53.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.14 Million | +28.76% |
| 2025 | ILA882.15K | -33.49% |
| 2024 | ILA1.33 Million | -58.95% |
| 2023 | ILA3.23 Million | -24.53% |
| 2022 | ILA4.28 Million | -81.46% |
| 2021 | ILA23.09 Million | -45.58% |
| 2020 | ILA42.43 Million | +83.50% |
| 2019 | ILA23.13 Million | +75.62% |
| 2018 | ILA13.17 Million | -44.03% |
| 2017 | ILA23.53 Million | -81.87% |
| 2016 | ILA129.75 Million | -93.48% |
| 2015 | ILA1.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Erech Finance Cahalacha Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.14 Million USD |
| MoneyControl | $1.14 Million USD |
| MarketWatch | $1.14 Million USD |
| marketcap.company | $1.14 Million USD |
| Reuters | $1.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Erech Finance Cahalacha Ltd
Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and private borrowers in Israel. It is also involved in the development of biomed-drugs in the areas of juvenile diabetes and cancer. The company was founded in 1998 and is based in Jerusalem, Israel.